Greg Pyszczymuka - Nov 6, 2024 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Commercial Officer
Signature
/s/ Mark Oki as attorney-in-fact for Greg Pyszczymuka
Stock symbol
AYTU
Transactions as of
Nov 6, 2024
Transactions value $
$0
Form type
4
Date filed
11/8/2024, 07:23 PM
Previous filing
Oct 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AYTU Employee Stock Option (Right to Buy) Award $0 +7K $0.00 7K Nov 6, 2024 Common Shares 7K $1.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 1/3 on November 6, 2025, with the remaining options vesting in 24 equal monthly installments beginning December 6, 2025.